Topic: Ventavia

Whistleblower Brooke Jackson, who worked on Pfizer's Phase 3 COVID-19 vaccine trial, reported widespread irregularities including mislabeled specimens and unblinded participants. Her testimony, featured on the British Medical Journal's YouTube channel, alleges that Ventavia and Pfizer ignored severe adverse events to maintain the trial's timeline.

The British Medical Journal (BMJ) published a report from whistleblower Brooke Jackson, a former regional director at Ventavia Research Group. Jackson alleges that the company falsified data, unblinded patients, and failed to follow up on adverse events during Pfizer's pivotal Phase 3 clinical trials in Texas. Despite notifying the FDA, Jackson was fired, and the trial data remained the basis for the vaccine's authorization.